论文部分内容阅读
近年来,肺结核联合化疗效果已被肯定。联合化疗通常用门服、肌注、静滴三种方法,极少数用气管内给药。我科从1989年10月起对30例浸润型肺结核住院病人采用抗痨药、酒精雾化吸入联合治疗,另以40例单纯四联化疗作对照,现将临床效果报告如下。临床资料一、病例选择诊断符合1982年全国结核病防治学术会议制定的标准。选择年龄、病情、病变性质、病变范围、空洞、痰菌等相似的初治病例随机分组:治疗组30例,均为男性;年龄15～30岁23例,31～40岁2例,41～50岁1例,50岁以上4例;痰菌阳性10例,阴性20例,全部病例无肺外结核及心、肝、肾等脏器疾病;3个月为1疗程。对照组40例,以ISRZ或ISRE四联化疗,3个月为1疗程。
In recent years, tuberculosis combined with chemotherapy has been affirmed. Combination chemotherapy usually door service, intramuscular injection, intravenous infusion of three kinds of methods, very few with endotracheal administration. Our department from October 1989 on 30 cases of infiltration of tuberculosis inpatients with anti-tuberculosis drugs, alcohol inhalation combination therapy, the other with 40 cases of simple quadruple chemotherapy as a control, the clinical results are reported as follows. Clinical data First, the diagnosis of case selection in line with the National Tuberculosis Prevention and Control Conference in 1982 developed standards. Thirty patients with similar initial treatment were randomly divided into treatment group (30 males), age 15-30 years (23 cases), 31-40 years old (2 cases), 41 cases (41 cases) 50 years old in 4 cases; sputum positive in 10 cases, negative in 20 cases, all cases without extra-pulmonary tuberculosis and heart, liver, kidney and other organ diseases; 3 months for a course of treatment. Control group of 40 patients with ISRZ or ISRE quadruple chemotherapy, 3 months for a course of treatment.